Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Offer Update

4 Aug 2005 09:43

Torex Retail PLC04 August 2005 Torex Retail plc4 August 2005 FOR IMMEDIATE RELEASE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN TOREX RETAIL PLC ___________________________________________________________________________ RECOMMENDED OFFER FOR XN CHECKOUT HOLDINGS PLC Offer Wholly Unconditional and Compulsory Acquisition of Outstanding XN Checkout Shares The Board of Torex Retail plc ("Torex Retail") announces that the offer (the"Offer") made by Evolution Securities Limited on behalf of Torex Retail for XNCheckout Holdings PLC ("XN Checkout") has today become wholly unconditional. As at 1.00 p.m. on 3 August 2005, valid acceptances had been received in respectof 26,884,727 XN Checkout Shares (representing approximately 96.03 per cent. ofXN Checkout's issued share capital). Accordingly, Torex Retail will shortly be issuing notices under s.429 CompaniesAct 1985 to XN Checkout Shareholders who have not yet accepted the Offer that itnow intends to exercise its rights to acquire compulsorily all those XN CheckoutShares still outstanding at the expiry of the requisite notice period. In themeantime, the Offer remains open for acceptance until further notice. Notice will also be sent to the Board of XN Checkout requesting that the XNCheckout Directors make an application to AiM for cancellation of the admissionof XN Checkout Shares to trading on AiM. XN Checkout Shareholders who have not yet accepted the Offer should, if theyhold their XN Checkout Shares in Certificated Form, despatch their Forms ofAcceptance as soon as possible or, if they hold their XN Checkout Shares inUncertificated Form accept the Offer electronically through CREST. XN CheckoutShareholders who are in any doubt as to the procedures for acceptance shouldcontact Capita Registrars by telephone on 0870 162 3121 or if calling fromoutside the United Kingdom on +44 208 639 2157. Settlement of consideration to which any XN Checkout Shareholder is entitledwill be effected: (i) in the case of acceptances received (complete in allrespects) by 4 August 2005 within 14 days of this date; or (ii) in the case ofacceptances received (complete in all respects) after 4 August 2005 but whilethe Offer remains open, within 14 days of such receipt. Terms defined in the Offer document dated 8 July 2005 shall, unless the contextrequires otherwise, have the same meanings in this announcement. EnquiriesTorex Retail Telephone: 01993 230 030Richard Thompson / Nigel Horn Evolution Telephone: 0207 071 4300Tim Worlledge / Jeremy Ellis This announcement is issued by Evolution which is authorised and regulated inthe United Kingdom by the Financial Services Authority. Evolution is actingexclusively for Torex Retail and is acting for no one else in connection withthe Offer and will not be responsible to anyone other than Torex Retail forproviding the protections afforded to customers of Evolution nor for providingadvice in relation to the Offer. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jul 20209:59 amRNSHoldings in Company
24th Jul 20207:00 amRNSCommencement of facility expansion plan
23rd Jul 20206:22 pmRNSHoldings in Company
17th Jul 20209:56 amRNSHoldings in Company
10th Jul 20203:18 pmRNSHoldings in Company
6th Jul 20209:31 amRNSHoldings in Company
3rd Jul 202010:01 amRNSHoldings in Company
30th Jun 20204:44 pmRNSTotal Voting Rights
30th Jun 202010:42 amRNSResult of AGM
23rd Jun 20203:07 pmRNSOption Exercise and Total Voting Rights
17th Jun 202012:57 pmRNSHoldings in Company
15th Jun 20202:06 pmRNSSecond Price Monitoring Extn
15th Jun 20202:00 pmRNSPrice Monitoring Extension
15th Jun 202011:31 amRNSHoldings in Company
11th Jun 20204:54 pmRNSHoldings in Company
11th Jun 20204:26 pmRNSHoldings in Company
11th Jun 20201:21 pmRNSHoldings in Company
11th Jun 202011:20 amRNSHoldings in Company
11th Jun 202011:05 amRNSSecond Price Monitoring Extn
11th Jun 202011:00 amRNSPrice Monitoring Extension
10th Jun 20204:53 pmRNSHoldings in Company
10th Jun 20204:51 pmRNSHoldings in Company
10th Jun 20204:49 pmRNSHoldings in Company
10th Jun 20204:35 pmRNSHoldings in Company
9th Jun 20201:10 pmRNSResult of General Meeting and Total Voting Rights
5th Jun 20209:15 amRNSDirector subscriptions/PDMR dealing
5th Jun 20207:00 amRNSAnnual results for the year ended 31 December 2019
4th Jun 20204:41 pmRNSSecond Price Monitoring Extn
4th Jun 20204:35 pmRNSPrice Monitoring Extension
3rd Jun 20202:05 pmRNSSecond Price Monitoring Extn
3rd Jun 20202:00 pmRNSPrice Monitoring Extension
1st Jun 20209:05 amRNSSecond Price Monitoring Extn
1st Jun 20209:00 amRNSPrice Monitoring Extension
1st Jun 20207:00 amRNSCE Mark awarded for OrthoPure XT
29th May 202011:05 amRNSSecond Price Monitoring Extn
29th May 202011:00 amRNSPrice Monitoring Extension
27th May 20204:41 pmRNSSecond Price Monitoring Extn
27th May 20204:36 pmRNSPrice Monitoring Extension
26th May 20207:00 amRNSPublication of circular and notice of GM
22nd May 20202:00 pmRNSPrice Monitoring Extension
22nd May 202011:05 amRNSSecond Price Monitoring Extn
22nd May 202011:00 amRNSPrice Monitoring Extension
22nd May 20207:00 amRNSConfirmation of successful fundraising
21st May 20204:47 pmRNSPrimaryBid.com Offer
21st May 20204:43 pmRNSProposed Equity Fundraise
11th May 20207:00 amRNSNew collaboration with leading healthcare company
20th Apr 20207:00 amRNSAdditional US government-backed loan secured
15th Apr 20207:00 amRNSUS Government backed loan extends cash runway
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.